ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1LLY - US5324571083 - Common Stock
907.8 EUR
+2.4 (+0.27%)
Taking everything into account, 1LLY scores 6 out of 10 in our fundamental rating. 1LLY was compared to 54 industry peers in the Pharmaceuticals industry. While 1LLY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1LLY is valued quite expensive, but it does show an excellent growth. These ratings would make 1LLY suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year 1LLY was profitable.
In the past year 1LLY had a positive cash flow from operations.
In the past 5 years 1LLY has always been profitable.
In the past 5 years 1LLY always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 16.02%, 1LLY belongs to the best of the industry, outperforming 92.45% of the companies in the same industry.
1LLY's Return On Equity of 77.38% is amongst the best of the industry. 1LLY outperforms 98.11% of its industry peers.
With an excellent Return On Invested Capital value of 28.84%, 1LLY belongs to the best of the industry, outperforming 96.23% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1LLY is significantly above the industry average of 13.79%.
The 3 year average ROIC (21.71%) for 1LLY is below the current ROIC(28.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
1LLY has a better Profit Margin (30.99%) than 98.11% of its industry peers.
1LLY's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 44.41%, 1LLY belongs to the top of the industry, outperforming 98.11% of the companies in the same industry.
1LLY's Operating Margin has improved in the last couple of years.
The Gross Margin of 1LLY (83.03%) is better than 88.68% of its industry peers.
In the last couple of years the Gross Margin of 1LLY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
1LLY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, 1LLY has about the same amount of shares outstanding.
1LLY has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1LLY has a worse debt to assets ratio.
2.2 Solvency
1LLY has an Altman-Z score of 8.39. This indicates that 1LLY is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 8.39, 1LLY belongs to the best of the industry, outperforming 94.34% of the companies in the same industry.
The Debt to FCF ratio of 1LLY is 6.60, which is on the high side as it means it would take 1LLY, 6.60 years of fcf income to pay off all of its debts.
1LLY has a Debt to FCF ratio of 6.60. This is comparable to the rest of the industry: 1LLY outperforms 41.51% of its industry peers.
A Debt/Equity ratio of 1.72 is on the high side and indicates that 1LLY has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.72, 1LLY is doing worse than 77.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.39 |
ROIC/WACC3.11
WACC9.26%
2.3 Liquidity
1LLY has a Current Ratio of 1.55. This is a normal value and indicates that 1LLY is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1LLY (1.55) is better than 64.15% of its industry peers.
A Quick Ratio of 1.24 indicates that 1LLY should not have too much problems paying its short term obligations.
1LLY has a Quick ratio of 1.24. This is in the better half of the industry: 1LLY outperforms 73.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
1LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.22%, which is quite impressive.
1LLY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.57% yearly.
The Revenue has grown by 45.41% in the past year. This is a very strong growth!
1LLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.08% yearly.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
3.2 Future
The Earnings Per Share is expected to grow by 31.53% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.88% on average over the next years. This is quite good.
EPS Next Y84.93%
EPS Next 2Y58.19%
EPS Next 3Y45.43%
EPS Next 5Y31.53%
Revenue Next Year41.01%
Revenue Next 2Y29.88%
Revenue Next 3Y25.23%
Revenue Next 5Y18.88%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 48.34, which means the current valuation is very expensive for 1LLY.
62.26% of the companies in the same industry are cheaper than 1LLY, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.39. 1LLY is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 32.68, the valuation of 1LLY can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 64.15% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, 1LLY is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.34 | ||
| Fwd PE | 32.68 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 69.81% of the companies listed in the same industry.
66.04% of the companies in the same industry are cheaper than 1LLY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 156.17 | ||
| EV/EBITDA | 36.68 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of 1LLY may justify a higher PE ratio.
A more expensive valuation may be justified as 1LLY's earnings are expected to grow with 45.43% in the coming years.
PEG (NY)0.57
PEG (5Y)2.92
EPS Next 2Y58.19%
EPS Next 3Y45.43%
5. Dividend
5.1 Amount
With a yearly dividend of 0.65%, 1LLY is not a good candidate for dividend investing.
1LLY's Dividend Yield is comparable with the industry average which is at 1.85.
With a Dividend Yield of 0.65, 1LLY pays less dividend than the S&P500 average, which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.65% |
5.2 History
On average, the dividend of 1LLY grows each year by 15.59%, which is quite nice.
Dividend Growth(5Y)15.59%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1LLY pays out 28.28% of its income as dividend. This is a sustainable payout ratio.
The dividend of 1LLY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.28%
EPS Next 2Y58.19%
EPS Next 3Y45.43%
BIT:1LLY (12/19/2025, 7:00:00 PM)
907.8
+2.4 (+0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap858.22B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts80.54
Price Target913.35 (0.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.65% |
Yearly Dividend4.21
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)15.92%
PT rev (3m)18.42%
EPS NQ rev (1m)1.69%
EPS NQ rev (3m)4.05%
EPS NY rev (1m)2.22%
EPS NY rev (3m)4.57%
Revenue NQ rev (1m)1.15%
Revenue NQ rev (3m)2.96%
Revenue NY rev (1m)1.69%
Revenue NY rev (3m)3.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.34 | ||
| Fwd PE | 32.68 | ||
| P/S | 16.92 | ||
| P/FCF | 156.17 | ||
| P/OCF | 62.58 | ||
| P/B | 42.24 | ||
| P/tB | 87.8 | ||
| EV/EBITDA | 36.68 |
EPS(TTM)18.78
EY2.07%
EPS(NY)27.78
Fwd EY3.06%
FCF(TTM)5.81
FCFY0.64%
OCF(TTM)14.51
OCFY1.6%
SpS53.67
BVpS21.49
TBVpS10.34
PEG (NY)0.57
PEG (5Y)2.92
Graham Number95.29
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROCE | 35.28% | ||
| ROIC | 28.84% | ||
| ROICexc | 33.25% | ||
| ROICexgc | 41.06% | ||
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% | ||
| FCFM | 10.83% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 1.44 | ||
| Cap/Depr | 507.66% | ||
| Cap/Sales | 16.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.78% | ||
| Profit Quality | 34.96% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 8.39 |
F-Score7
WACC9.26%
ROIC/WACC3.11
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y84.93%
EPS Next 2Y58.19%
EPS Next 3Y45.43%
EPS Next 5Y31.53%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year41.01%
Revenue Next 2Y29.88%
Revenue Next 3Y25.23%
Revenue Next 5Y18.88%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year101.24%
EBIT Next 3Y46.41%
EBIT Next 5Y32.15%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%
ELI LILLY & CO / 1LLY.MI FAQ
What is the fundamental rating for 1LLY stock?
ChartMill assigns a fundamental rating of 6 / 10 to 1LLY.MI.
Can you provide the valuation status for ELI LILLY & CO?
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (1LLY.MI). This can be considered as Overvalued.
Can you provide the profitability details for ELI LILLY & CO?
ELI LILLY & CO (1LLY.MI) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for 1LLY stock?
The Price/Earnings (PE) ratio for ELI LILLY & CO (1LLY.MI) is 48.34 and the Price/Book (PB) ratio is 42.24.
How financially healthy is ELI LILLY & CO?
The financial health rating of ELI LILLY & CO (1LLY.MI) is 5 / 10.